The NUAK Protein: A Key Regulator of Protein-Protein Interactions and Potential Drug Target

Target Name: NUAK Family SNF1-like Kinase (nonspcified subtype)

NCBI ID: P32313

Other Name(s): NUAK

The NUAK Protein: A Key Regulator of Protein-Protein Interactions and Potential Drug Target

The NUAK Family SNF1-like Kinase (nonspcified subtype) (NUAK) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the SNF1 family of kinases, which are known for their role in regulating protein-protein interactions and signaling pathways. The NUAK gene has been identified and its function is being studied extensively.

The NUAK gene was first identified in the genomic database using bioinformatics analysis. It is located on chromosome 16 and has a coding region of approximately 210 amino acids. The NUAK protein is a type of kinase that is characterized by its N-terminal region, which has a conserved catalytic core and a variable catalytic region. The variable catalytic region includes a unique feature called a nucleotide-binding oligomerization (NBO) domain, which is known for its ability to form a stable complex with nucleotides.

The NBO domain is a key feature of the NUAK protein that gives it its unique structure and function. It is a small, distinct domain that is located at the N-terminus of the protein and consists of a nucleotide-binding oligomerization (NBO) domain and a catalytic domain. The NBO domain is responsible for the protein's catalytic activity, as well as its ability to form stable interactions with nucleotides.

The NUAK protein is involved in a variety of cellular processes, including cell signaling, DNA replication, and protein-protein interactions. It is a key regulator of the protein-protein interaction between the protein kinase (PK) and its target proteins. NUAK protein is also involved in the regulation of DNA replication, cell signaling, and cell survival.

The NUAK gene has been implicated in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. It is also a potential drug target for several pharmaceutical companies. The NUAK protein is a promising biomarker for the diagnosis and treatment of these diseases.

The NUAK protein is also a potential drug target for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. The NUAK protein is a promising biomarker for the diagnosis and treatment of these diseases. For example, studies have shown that inhibiting the NUAK protein has anti-tumor and anti-inflammatory effects in cancer cells. It is also being investigated as a potential treatment for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In conclusion, the NUAK Family SNF1-like Kinase (nonspcified subtype) (NUAK) is a protein that is expressed in various tissues throughout the body and is involved in a variety of cellular processes. It is a key regulator of the protein-protein interaction between the protein kinase (PK) and its target proteins and is also involved in the regulation of DNA replication, cell signaling, and cell survival. The NUAK gene has been implicated in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. It is also a potential drug target for these diseases and has anti-tumor and anti-inflammatory effects in cancer cells. Further research is needed to fully understand the role of the NUAK protein in these diseases and its potential as a drug target.

Protein Name: NUAK Family SNF1-like Kinase (nonspcified Subtype)

More Common Targets